Drug Discovery / ADME

Distinct cell-based and enzymatic assays must be used to evaluate the ADME-Tox properties of compounds (bioavailability and toxicity of drug candidates) early in the drug discovery process to meet regulatory requirements and to ensure suitability for further developmental steps, while other assays are used to study the efficacy of a drug candidate for curing a particular malfunction.

PromoCell provides a wide choice of products/assays that are essential in drug screening/development and testing (e.g. liver metabolism & clearance, liver function marker, renal clearance & function marker, drug/metabolite transporter assays).